See also this year's filing and all EDGAR filings for this company.
PDF Report 0001725160_2023_Zentalis_Pharmaceuticals_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001725160, Zentalis Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 451,933,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,736,000 |
| 2 | PropertyPlantAndEquipmentNet | 7,705,000 |
| 3 | remainder_Assets | 75,936,000 |
| 4 | LiabilitiesCurrent | 56,647,000 |
| 5 | LiabilitiesNoncurrent | 47,786,000 |
| 6 | remainder_Liabilities | 853,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 54,553,000 |
| 9 | ResearchAndDevelopmentExpense | 172,734,000 |
| 10 | remainder_Expenses | -469,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -10,295,000 |
| 13 | remainder_ComprehensiveNetIncome | -921,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 539,310,000 |
| 1 | Liabilities | 105,286,000 |
| 2 | Expenses | 226,818,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 434,024,000 |
| 5 | NetIncome | -237,113,000 |
| 6 | ComprehensiveNetIncome | -237,573,500 |
| 7 | BaseVar | 441,315,000 |
| 8 | EconomicCapitalRatio | 1.58 |
Edgar->Model Mapping
Feature Distribution
Change over Time
